A case of venlafaxine-induced inhibition of T-lymphocyte proliferation.
Denys
Damiaan
D
Department of Psychiatry, University Medical Center, Utrecht, The Netherlands. d.a.j.p.denys@azu.nl
Kavelaars
Annemieke
A
Heijnen
Cobi J
CJ
Westenberg
Herman
H
D003511:Cyclohexanols / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects*; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000276:immunology; D012008:Recurrence; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012852:Sinusitis / Q000139:chemically induced / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects*; D000069470:Venlafaxine Hydrochloride
D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride